RTTNews | Mar 29, 2021 08:45PM EDT

20:45 Monday, March 29, 2021 (RTTNews) - Astellas' XOSPATA Meets OS Endpoint In COMMODORE Trial Of Patients With Relapsed Or Refractory AML With FLT3 Mutation

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved